-
Offers expanded coverage of autoinflammatory diseases, plus new chapters on Takayasu Arteritis and Other Vasculitides, Mechanistic Investigation of Pediatric Rheumatic Diseases, Genetics and Pediatric Rheumatic Diseases, and Global Issues in Pediatric Rheumatology.
-
Reflects the changes in diagnosis, monitoring, and management that recent advances have made possible.
-
Covers the latest information on small molecule treatment, biologics, biomarkers, epigenetics, biosimilars, and cell-based therapies, helping you choose treatment protocols based on the best scientific evidence available today.
-
Features exhaustive reviews of the complex symptoms, signs, and lab abnormalities that characterize these clinical disorders.
-
Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Authors
Ross E. Petty Professor Emeritus, Pediatric Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. Ross E. Petty is a Canadian pediatric rheumatologist. He is a professor emeritus in the Department of Pediatrics at the University of British Columbia and a pediatric rheumatologist at BC Children's Hospital in Vancouver, Canada. He established Canada's first formal pediatric rheumatology program at the University of Manitoba in 1976, and three years later, he founded a similar program at the University of British Columbia.In 2006, he was appointed a member of the Order of Canada for his contribution within Canada and around the world to improving the lives of children and youth with rheumatic diseases. In 2012, he was awarded a Queen Elizabeth II Diamond Jubilee medal. Petty has contributed more than 225 original research papers and book chapters in medical and scientific journals. Ronald M. Laxer Professor, Departments of Pediatrics and Medicine, University of Toronto; Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada. Dr. Ronald Laxer is an active staff physician in the Division of Rheumatology, and was an inaugural Division Head at the Hospital for Sick Children in Toronto. He is internationally recognized in the field of autoinflammatory disease and has been a part of genetic discoveries of several new autoinflammatory diseases. In addition to co-editing the Textbook of Pediatric Rheumatology, he is a co-editor of the Textbook of Autoinflammation. His recent achievements include receiving the American College of Rheumatology Master Designation Award from the American College of Rheumatology and the CRA Master Award from the Canadian Rheumatology Association. In 2020, he was appointed to the Covid-19 Government of Canada Task Force addressing gaps related to care for children. Carol B Lindsley Professor, Department of Pediatrics, University of Kansas School of Medicine; Chief of Pediatric Rheumatology, Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas. Lucy Wedderburn Professor in Paediatric Rheumatology, Institute of Child Health, University College London; Consultant in Paediatric Rheumatology, Department of Rheumatology
Great Ormond Street Hospital National Health Service Trust, London, Great Britain. Lucy Wedderburn is Professor in Paediatric Rheumatology at UCL (Institute of Child Health), Director of Arthritis Research UK Centre for Adolescent Rheumatology at UCL, and UCL Hospitals/GOSH consultant. Her research interests are T cell immunology, immune regulation and muscle biology, with a major focus upon human T cell responses and immune regulation. In particular, the autoimmune conditions of childhood, including Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM); the mechanisms which allow survival and expansion of inflammatory T cells within the joint, the control of their production of cytokines and chemokines, and their contribution to disease. She trained in Cambridge and then London in Immunology and Rheumatology and then spent time training in science at the University of Stanford, USA, before returning to the University College London and Great Ormond Street Hospital on a Wellcome Trust Fellowship. Robert C Fuhlbrigge Children's Hospital Colorado
University of Colorado- Denver. Elizabeth D. Mellins Department of Pediatrics
Stanford University School of Medicine.